Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alyssa, Guido"'
Autor:
Maria L. Adelus, Kristi M. Sprowl, Tanwe C. Shende, Lori E. Fantry, Carlos M. Perez-Velez, Alyssa Guido, Julia M. Fisher, Edward J. Bedrick, Taylor M. Drake
Publikováno v:
Journal of community health. 45(2)
HIV pre-exposure prophylaxis (PrEP) is underutilized among Hispanics, women, and low-income individuals. To better understand PrEP barriers in this population, questionnaires were administered to 500 patients attending public health clinics in southe
Autor:
Maribel Gonzalez, Harold P. Katner, Alyssa Guido, John Nelson, Anna Kinder, Jason Henry, Charlotte Ledonne, H. Irene Hall, Anna Satcher Johnson, Jennifer Janelle, Xiaohong Hu, Donna Sweet, Jeanne Harris, Theresa Bramel, Natalia Martínez Paz
Publikováno v:
The Journal of Rural Health. 34:63-70
Purpose The HIV care continuum is used to monitor success in HIV diagnosis and treatment among persons living with HIV in the United States. Significant differences exist along the HIV care continuum between subpopulations of people living with HIV;
Autor:
John A, Nelson, Anna, Kinder, Anna Satcher, Johnson, H Irene, Hall, Xiaohong, Hu, Donna, Sweet, Alyssa, Guido, Harold, Katner, Jennifer, Janelle, Maribel, Gonzalez, Natalia Martínez, Paz, Charlotte, Ledonne, Jason, Henry, Theresa, Bramel, Jeanne, Harris
Publikováno v:
The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 34(1)
The HIV care continuum is used to monitor success in HIV diagnosis and treatment among persons living with HIV in the United States. Significant differences exist along the HIV care continuum between subpopulations of people living with HIV; however,
Autor:
Alyssa Guido, Cesar Egurrola, Stephen A. Klotz, Spencer Schaff, Shannon Smith, Anca Georgescu, Julia M. Fisher, Catalin Florita
Publikováno v:
Open Forum Infectious Diseases
Background Despite expansion of antiretroviral therapy in recent years and growing evidence for PrEP (pre exposure prophylaxis) efficacy, HIV incidence has continued to rise while PrEP uptake has remained low, particularly in populations at risk. Our